Search Options Stock News and Analysis

REGN Flat Despite COVID-19 Antibody Drug Update

https://www.schaeffersresearch.com/content/news/2020/08/04/regn-flat-despite-covid-19-antibody-drug-update

8/4/2020 10:18 AM

The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are trading sideways this morning at $644.66, even though the biotechnology company announced the coronavirus antibody drug it is developing ...

Expedited COVID-19 Trials Give REGN a Boost

https://www.schaeffersresearch.com/content/news/2020/07/06/expedited-covid-19-trials-give-regn-a-boost

7/6/2020 9:41 AM

Biotech Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is getting a boost this morning after news that it's starting phase 3 trials for its antibody drug cocktail to treat COVID-19. This trial comes jus...

REGN Could Take a Breather This Month

https://www.schaeffersresearch.com/content/analysis/2020/06/04/regn-could-take-a-breather-this-month

6/4/2020 1:41 PM

Over the past two weeks, we've been exploring some of the best S&P 500 stocks to own in June, historically. Now, with help from Schaeffer's Senior Quantitative Analyst Rocky White, we'll shift gears...

Drug Stock Stays Hot After COVID-19 Treatment Update

https://www.schaeffersresearch.com/content/analysis/2020/03/17/drug-stock-stays-hot-after-covid-19-treatment-update

3/17/2020 2:27 PM

One of the best stocks on the Nasdaq today is Regeneron Pharmaceuticals Inc (NASDAQ:REGN), last seen up 10.8% to trade at $488.42. This comes after the drugmaker announced it had identified hundreds o...

Put Buying Picks Up During Regeneron Stock Rally

https://www.schaeffersresearch.com/content/options/2019/12/13/put-buying-picks-up-during-regeneron-stock-rally

12/13/2019 2:45 PM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has been rallying hard since its lows near $270 from early October, checking in 0.9% higher today at $375.40 -- which would be its best close since April --...

PEOPLE ALSO SEARCH FOR